开发和验证一种UPLC-MS/MS方法,用于在人体血中确定阿帕胺,并将其应用于生物等价性研究
Qi Wen1,2, Juan Cai1,2, Min Yang1,2
1Bioanalytical Service Center of Sichuan Institute for Drug Control, Chengdu, China.
Biomedical chromatography : BMC
|March 11, 2026
概括
一种新的UPLC-MS/MS方法准确地测量了血中的阿帕胺 (APT) 用于生物等价性研究. 在禁食和食条件下,两种阿帕胺片配方被发现是生物等价的.
科学领域:
- 分析化学 分析化学
- 药理动力学 药理动力学
- 制药科学 制药科学
背景情况:
- 阿帕胺 (APT) 是一种关键的药物,需要在生物矩阵中精确量化.
- 生物等价性研究对于批准仿制药和确保治疗等价性至关重要.
研究的目的:
- 开发和验证一种敏感的UPLC-MS/MS方法,用于确定人体血中阿帕胺 (APT) 度.
- 为了评估两个不同的阿帕胺片配方的生物等价性.
主要方法:
- 超高性能液体染色学-并联质谱学 (UPLC-MS/MS) 用于样本分析.
- 血样本经过蛋白质沉,然后在C18柱上进行分离.
- 在食和禁食条件下进行了交叉生物等价性研究.
主要成果:
- 开发的UPLC-MS/MS方法表现出卓越的线性,准确性和精度.
- 没有观察到显著的矩阵效应,恢复率始终很高.
- 对于Cmax和AUC0-72比率的90%置信区间满足了生物等价性标准 (80.00%125.00%).
结论:
- 该UPLC-MS/MS方法是可靠的,快速的,适合在血中例行量化阿帕胺.
- 经过测试的阿帕胺片剂配方被证明与参考配方具有生物等价性.
更多相关视频
相关概念视频
Measurement of Bioavailability: Pharmacokinetic Methods
526
Pharmacokinetics is a vital branch of pharmacology that examines how drugs are absorbed, distributed, metabolized, and excreted by the body. Two key methodologies in pharmacokinetics are plasma drug concentration studies and urinary drug excretion analyses, both of which provide critical insights into a drug's therapeutic efficacy and bioavailability.Plasma Drug Concentration-Time StudiesPlasma drug concentration-time studies involve analyzing blood samples at specific intervals to quantify...
526
Bioequivalence studies: Biowaivers
433
In certain scenarios, in vitro dissolution tests can replace in vivo bioequivalence studies. This is particularly true when a drug product, though available in varying strengths, maintains proportional similarity in its active and inactive ingredients. In such cases, the need for in vivo bioequivalence studies for lower strength variants may be waived, provided dissolution tests and in vivo studies on the highest strength yield satisfactory results.Bioequivalence can be indicated through...
433


